Yes the “expected to be wrapping up” is classic and...

Yes the “expected to be wrapping up” is classic and long-standing Jackie speak and gives lots of non-committal wriggle room for further delays IMO. I have my own thoughts regarding timelines for readouts and partnerships that I’ve detailed previously in another thread.

Anyway, FYI my notes from the Q&A clearly indicate that part-time Jackie said that we can expect all 3 in-house DEP drugs to complete and read out in CY22. With Docetaxel and Cabazitaxel to possibly read out in H1 CY22. As I said they’re just my notes so should not be relied upon. Shame that 2022 technology wasn’t able to keep the Q&A on the Starpharma website…..*eye roll.